(3S,5S)-Atorvastatin (sodium salt)
(3S,5S)-Atorvastatin (sodium salt) Basic information
- Product Name:
- (3S,5S)-Atorvastatin (sodium salt)
- Synonyms:
-
- Atorvastatin impurity 32/(3S,5S)-Atorvastatin Sodium Salt/Atorvastatin EP Impurity E Sodium Salt/(3S,5S)-Atorvastatin Calcium Salt/((3S,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) Sodium Sal
- Atorvastatin impurity 32/(3S,5S)-Atorvastatin Sodium Salt/Atorvastatin EP Impurity E Sodium Salt/(3S,5S)-Atorvastatin Calcium Salt/((3S,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) Sodium Salt
- Atorvastatin EP Impurity E Sodium Salt
- CAS:
- 1428118-38-0
- MF:
- C33H36FN2NaO5
- MW:
- 582.65
- Mol File:
- 1428118-38-0.mol
(3S,5S)-Atorvastatin (sodium salt) Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- ≤0.5mg/ml in ethanol;15mg/ml in DMSO;25mg/ml in dimethyl formamide
- form
- crystalline solid
- Stability:
- Hygroscopic
(3S,5S)-Atorvastatin (sodium salt) Usage And Synthesis
Uses
(3S,5S)-Atorvastatin Sodium Salt (Atorvastatin EP Impurity E) is a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
Biological Activity
atorvastatin exists in four optical forms. the (3r, 5r)-atorvastatin enantiomer displays the greatest activity against hmg-coa reductase. (3s,5s)-atorvastatin is an enantiomer of atorvastatin with little or no inhibitory activity against hmg-coa reductase [1]. atorvastatin is a synthetic hmg-coa reductase inhibitor implicated in lowering plasma cholesterol levels by inhibiting endogenous cholesterol synthesis. atorvastatin also reduces triglyceride levels through an as yet unproven mechanism [2]. in various trials in patients with hypercholesterolaemia, atorvastatin produced greater reductions in total cholesterol, apolipoprotein b, ldl-cholesterol and triglyceride levels. in patients with primary hypercholesterolaemia, atorvastatin in combination with colestipol produced significant reductions in ldl-cholesterol levels and smaller reductions in triglyceride levels than atorvastatin monotherapy [2].
References
[1] kocarek t a, dahn m s, cai h, et al. regulation of cyp2b6 and cyp3a expression by hydroxymethylglutaryl coenzyme a inhibitors in primary cultured human hepatocytes[j]. drug metabolism and disposition, 2002, 30(12): 1400-1405.
[2] lea a p, mctavish d. atorvastatin[j]. drugs, 1997, 53(5): 828-847.
(3S,5S)-Atorvastatin (sodium salt)Supplier
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 18096642264
- sales@foreversyn.com
- Tel
- 18096409024
- sales02@foreversyn.com
- Tel
- 18818260767
- sales@chemegen.com
- Tel
- 021-69568360 18916172912
- order@med-bio.cn